Efficacy of obstetric thromboprophylaxis and long-term risk of recurrence of venous thromboembolism

Acta Obstetricia et Gynecologica Scandinavica

Volumn 90, Issue 6, 2011, Pages 648-653

  Lindqvist, Pelle G ^a   Bremme, Katarina ^a   Hellgren, Margareta ^b,c  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^c Sahlgrenska University Hospital Gothenburg ^*  (Sweden)

Author keywords

bleeding complications; efficacy; intrauterine growth restriction; placental abruption; preeclampsia; Pregnancy; recurrence; thromboprophylaxis; venous thrombosis

Indexed keywords

DALTEPARIN; ENOXAPARIN;

ADULT; ARTICLE; BLEEDING; CONTROLLED CLINICAL TRIAL; DRUG EFFICACY; FEMALE; HEMATOMA; HOSPITAL; HUMAN; INTRAUTERINE GROWTH RETARDATION; LUNG EMBOLISM; MAJOR CLINICAL STUDY; PREECLAMPSIA; PREGNANT WOMAN; PREMATURE LABOR; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECURRENT DISEASE; RISK; RISK REDUCTION; SMALL FOR DATE INFANT; SOLUTIO PLACENTAE; SWEDEN; VENOUS THROMBOEMBOLISM;

ADULT; ANTICOAGULANTS; DELIVERY, OBSTETRIC; FEMALE; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; INCIDENCE; ODDS RATIO; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PROSPECTIVE STUDIES; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; SWEDEN; VENOUS THROMBOEMBOLISM;

EID: 79956223258     PISSN: 00016349     EISSN: 16000412     Source Type: Journal    
DOI: 10.1111/j.1600-0412.2011.01098.x     Document Type: Article

References (31)

1. Marik PE, Plante LA,. Venous thromboembolic disease and pregnancy. N Engl J Med. 2008; 359: 2025-33.
2. Chunila SD, Bates SM,. Venous thromboembolism in pregnancy: diagnosis, management and prevention. Thromb Haemost. 2009; 101: 428-38.
3. Bremme K,. Haemostatic changes in pregnancy. Best Pract Res Clin Haematol. 2003; 16: 153-68.
4. Lindqvist PG, Dahlbäck B, Marsál K,. Thrombotic risk during pregnancy: a population study. Obstet Gynecol. 1999; 94: 595-9. (Pubitemid 29460947)
5. Bergqvist A, Bergqvist D, Hallböök T,. Deep vein thrombosis during pregnancy. A prospective study. Acta Obstet Gynecol Scand. 1983; 62: 443-8. (Pubitemid 14213532)
6. Jacobsen AF, Skjeldestad FE, Sandset PM,. Ante- and postnatal risk factors of venous thrombosis: a hospital-based case-control study. J Thromb Haemost. 2008; 6: 905-12. (Pubitemid 351689910)
7. Knight M,. Antenatal pulmonary embolism: risk factors, management and outcomes. BJOG. 2008; 115: 453-61. (Pubitemid 351225139)
8. Why mothers die, 2003-2005 report. 2007. (accessed 23 March 2011).
9. Samuelsson E, Hellgren M, Högberg U,. Pregnancy-related deaths due to pulmonary embolism in Sweden. Acta Obstet Gynecol Scand. 2007; 86: 435-43. (Pubitemid 46747702)
10. De Stefano V, Martinelli I, Rossi E, Battaglioli T, Za T, Mannuccio Mannucci P, et al,. The risk of recurrent venous thromboembolism in pregnancy and puerperium without antithrombotic prophylaxis. Br J Haematol. 2006; 135: 386-91. (Pubitemid 44484848)
11. Badaracco MA, Vessey MP,. Recurrence of venous thromboembolic disease and use of oral contraceptives. Br Med J. 1974; 1: 215-7.
12. Tengborn L, Bergqvist D, Mätzsch T, Bergqvist A, Hedner U,. Recurrent thromboembolism in pregnancy and puerperium. Is there a need for thromboprophylaxis? Am J Obstet Gynecol. 1989; 160: 90-4. (Pubitemid 19055265)
13. Brill-Edwards P, Ginsberg JS, Gent M, Hirsh J, Burrows R, Kearon C, et al,. Safety of withholding heparin in pregnant women with a history of venous thromboembolism. Recurrence of Clot in This Pregnancy Study Group. N Engl J Med. 2000; 343: 1439-44.
14. Pabinger I, Grafenhofer H, Kaider A, Kyrle PA, Quehenberger P, Mannhalter C, et al,. Risk of pregnancy-associated recurrent venous thromboembolism in women with a history of venous thrombosis. J Thromb Haemost. 2005; 3: 949-54. (Pubitemid 41632825)
15. Lindqvist PG, Hellgren M, Nord E, Nyman M,. Beslut om trombosprofylax vid graviditet-enklare med riskpoäng. Läkartidningen. 2006; 103: 1429-32. (Pubitemid 43736027)
16. Lindqvist PG, Torsson J, Almqvist å, Björgell O,. Postpartum thromboembolism: severe events might be preventable using a new risk score model. Vasc Health Risk Manag. 2008; 4: 1081-7.
17. Ekman-Ordeberg G, Akerud A, Dubicke A, Malmström A, Hellgren M,. Does low molecular weight heparin shorten term labor? Acta Obstet Gynecol Scand. 2010; 89: 147-50.
18. Isma N, Svensson PJ, Lindblad B, Lindqvist PG,. The effect of low molecular weight heparin (dalteparin) on duration and initiation of labor. J Thromb Thrombolysis. 2009 Dec 1. (Epub ahead of print).
19. Blombäck M, Bremme K, Hellgren M, Siegbahn A, Lindberg H,. Thromboprophylaxis with low molecular mass heparin, 'Fragmin' (dalteparin), during pregnancy-a longitudinal safety study. Blood Coagul Fibrinolysis. 1998; 9: 1-9. (Pubitemid 28144411)
20. Dahlman TC, Hellgren MS, Blombäck M,. Thrombosis prophylaxis in pregnancy with use of subcutaneous heparin adjusted by monitoring heparin concentration in plasma. Am J Obstet Gynecol. 1989; 161: 420-5.
21. Levine MN, Gent M, Hirsh J, Weitz J, Turpie AG, Powers P, et al,. Ardeparin (low-molecular-weight heparin) vs graduated compression stockings for the prevention of venous thromboembolism. A randomized trial in patients undergoing knee surgery. Arch Intern Med. 1996; 156: 851-6. (Pubitemid 26119812)
22. Wirth T, Schneider B, Misselwitz F, Lomb M, Tüylü H, Egbring R, et al,. Prevention of venous thromboembolism after knee arthroscopy with low-molecular weight heparin (reviparin): Results of a randomized controlled trial. Arthroscopy. 2001; 17: 393-9.
23. Lindqvist PG, Epstein E, Olsson H,. The relationship between lifestyle factors and venous thromboembolism among women: a report from the MISS study. Br J Haematol. 2009; 144: 234-40.
24. Schulman S, Rhedin AS, Lindmarker P, Carlsson A, Lärfars G, Nicol P, et al,. A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. Duration of Anticoagulation Trial Study Group. N Engl J Med. 1995; 332: 1661-5.
25. Rodger MA, Kahn SR, Wells PS, Anderson DA, Chagnon I, Le Gal G, et al,. Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapy. CMAJ. 2008; 179: 417-26.
26. Kyrle PA, Minar E, Bialonczyk C, Hirschl M, Weltermann A, Eichinger S,. The risk of recurrent venous thromoembolism in men and women. N Engl J Med. 2004; 350: 2558-63.
27. Palmgren J, Kirkinen P,. Venous circulation in the maternal lower limb: a Doppler study with the Vasalva maneuver. Ultrasound Obstet Gynecol. 1996; 8: 93-7. (Pubitemid 126720502)
28. Clarke M, Hopewell S, Juszczak E, Eisinga A, Kjeldstrøm M,. Compression stockings for preventing deep vein thrombosis in airline passengers. Cochrane Database Syst Rev. 2006; 19: CD004002.
29. Lindqvist PG, Epstein E, Olsson H,. Does an active sun exposure habit lower the risk of venous thrombotic events? A D-lightful hypothesis. J Thromb Haemost. 2009; 7: 605-10.
30. Greer IA, Nelson-Piercy C,. Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy. Blood. 2005; 106: 401-7. (Pubitemid 40981229)
31. Blanco-Molina A, Trujillo-Santos J, Criado J, Lopez L, Lecumberri R, Gutierrez R, et al,. Venous thromboembolism during pregnancy and puerperium: findings from the RIETE registry. Thromb Haemost. 2007; 97: 186-90. (Pubitemid 46592137)